Length of initial prescription at hospital discharge and long-term medication adherence for elderly, post-myocardial infarction patients: a population-based interrupted time series study

J D Schwalm, Noah M Ivers, Zachary Bouck, Monica Taljaard, Madhu K Natarajan, Francis Nguyen, Waseem Hijazi, Kednapa Thavorn, Lisa Dolovich, Tara McCready, Erin O'Brien, Jeremy M Grimshaw, J D Schwalm, Noah M Ivers, Zachary Bouck, Monica Taljaard, Madhu K Natarajan, Francis Nguyen, Waseem Hijazi, Kednapa Thavorn, Lisa Dolovich, Tara McCready, Erin O'Brien, Jeremy M Grimshaw

Abstract

Background: Preliminary evidence suggests that providing longer duration prescriptions at discharge may improve long-term adherence to secondary preventative cardiac medications among post-myocardial infarction (MI) patients. We implemented and assessed the effects of two hospital-based interventions-(1) standardized prolonged discharge prescription forms (90-day supply with 3 repeats for recommended cardiac medications) plus education and (2) education only-on long-term cardiac medication adherence among elderly patients post-MI.

Methods: We conducted an interrupted time series study of all post-MI patients aged 65-104 years in Ontario, Canada, discharged from hospital between September 2015 and August 2018 with ≥ 1 dispensation(s) for a statin, beta blocker, angiotensin system inhibitor, and/or secondary antiplatelet within 7 days post-discharge. The standardized prolonged discharge prescription forms plus education and education-only interventions were implemented at 2 (1,414 patients) and 4 (926 patients) non-randomly selected hospitals in September 2017 for 12 months, with all other Ontario hospitals (n = 143; 18,556 patients) comprising an external control group. The primary outcome, long-term cardiac medication adherence, was defined at the patient-level as an average proportion of days covered (over 1-year post-discharge) ≥ 80% across cardiac medication classes dispensed at their index fill. Primary outcome data were aggregated within hospital groups (intervention 1, 2, or control) to monthly proportions and independently analyzed using segmented regression to evaluate intervention effects. A process evaluation was conducted to assess intervention fidelity.

Results: At 12 months post-implementation, there was no statistically significant effect on long-term cardiac medication adherence for either intervention-standardized prolonged discharge prescription forms plus education (5.4%; 95% CI - 6.4%, 17.2%) or education only (1.0%; 95% CI - 28.6%, 30.6%)-over and above the counterfactual trend; similarly, no change was observed in the control group (- 0.3%; 95% CI - 3.6%, 3.1%). During the intervention period, only 10.8% of patients in the intervention groups received ≥ 90 days, on average, for cardiac medications at their index fill.

Conclusions: Recognizing intervention fidelity was low at the pharmacy level, and no statistically significant post-implementation differences in adherence were found, the trends in this study-coupled with other published retrospective analyses of administrative data-support further evaluation of this simple intervention to improve long-term adherence to cardiac medications.

Trial registration: ClinicalTrials.gov : NCT03257579 , registered June 16, 2017 Protocol available at: https://pubmed.ncbi.nlm.nih.gov/33146624/ .

Keywords: Adherence; Policy change; Post-myocardial infarction; Secondary prevention; Standardized discharge prescription form.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Flow of participants into the study. Notes: CAD = coronary artery disease; MI = myocardial infarction; DAD = Discharge Abstract Database. *For patient-level analyses, a threshold-based exclusion (i.e., minimum 180 eligible patients per site) was applied to facilitate model convergence, resulting in 14,344 patients (9,429 pre- and 4,915 post-intervention) across 26 sites in the control group
Fig. 2
Fig. 2
Monthly proportion of post-myocardial infarction patients age 65 and older with long-term cardiac medication adherence at one year from hospital discharge from September 2015 to August 2018 in Ontario, Canada by intervention group: a) Standardized prolonged discharge prescription forms plus education, (2 sites, 1414 patients); b) education only (4 sites, 926 patients); c) control (143 sites, 18556 patients). Notes: Observed values are denoted by ‘x’, solid blue lines represent the fitted regression pre- and post-intervention trendlines, and the hatched blue line represents the projected pre-intervention trend assuming there was no intervention (i.e., the counterfactual)

References

    1. Smith SC, Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2458. doi: 10.1161/CIR.0b013e318235eb4d.
    1. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: developed in collaboration with the Canadian cardiovascular society endorsed by the American Academy of family physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the Management of Patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation. 2008;117:296. doi: 10.1161/CIRCULATIONAHA.107.188209.
    1. Fitchett DH, Theroux P, Brophy JM, Cantor WJ, Cox JL, Gupta M, et al. Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment—part 2: ST-segment elevation myocardial infarction. Can J Cardiol. 2011;27(Suppl A):S402. doi: 10.1016/j.cjca.2011.08.107.
    1. Ivers NM, Schwalm JD, Jackevicius CA, Guo H, Tu JV, Natarajan M. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study. Can J Cardiol. 2013;29:1408. doi: 10.1016/j.cjca.2013.04.009.
    1. Tu JV, Donovan LR, Lee DS, Wang JT, Austin PC, Alter DA, et al. Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA. 2009;302:2330. doi: 10.1001/jama.2009.1731.
    1. Ahmad M, Schwalm JD, Velianou JL, Natarajan MK. Impact of routine in-hospital assessment of low-density lipoprotein levels and standardized orders on statin therapy in patients undergoing percutaneous coronary interventions. J Invasive Cardiol. 2005;17:518.
    1. Newby LK, Allen Lapointe NM, Chen AY, Kramer JM, Hammill BG, Delong ER, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203. doi: 10.1161/CIRCULATIONAHA.105.505636.
    1. Hudson M, Richard H, Pilote L. Parabolas of medication use and discontinuation after myocardial infarction—are we closing the treatment gap? Pharmacoepidemiol Drug Saf. 2007;16:773. doi: 10.1002/pds.1414.
    1. Shah ND, Dunlay SM, Ting HH, Montori VM, Thomas RJ, Wagie AE, et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med. 2009;122:961.e7–961.e13. doi: 10.1016/j.amjmed.2008.12.021.
    1. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177. doi: 10.1001/jama.297.2.177.
    1. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155:772. doi: 10.1016/j.ahj.2007.12.011.
    1. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028. doi: 10.1161/CIRCULATIONAHA.108.768986.
    1. Sabate E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
    1. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JM, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803. doi: 10.1161/CIRCULATIONAHA.106.618066.
    1. Hope CJ, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm. 2004;61:2043. doi: 10.1093/ajhp/61.19.2043.
    1. Batal HA, Krantz MJ, Dale RA, Mehler PS, Steiner JF. Impact of prescription size on statin adherence and cholesterol levels. BMC Health Serv Res. 2007;7:175. doi: 10.1186/1472-6963-7-175.
    1. Steiner JF, Robbins LJ, Roth SC, Hammond WS. The effect of prescription size on acquisition of maintenance medications. J Gen Intern Med. 1993;8:306. doi: 10.1007/BF02600143.
    1. Rymer JA, Fonseca E, Bhandary DD, Kumar D, Khan ND, Wang TY. Difference in medication adherence between patients prescribed a 30-day versus 90-day supply after acute myocardial infarction. Am Heart J. 2020;10(1). 10.1161/JAHA.119.016215.
    1. Presseau J, Schwalm JD, Grimshaw JM, Witteman HO, Natarajan MK, Linklater S, et al. Identifying determinants of medication adherence following myocardial infarction using the theoretical domains framework and the health action process approach. Psychol Health. 2017;32(10):1176–1194. doi: 10.1080/08870446.2016.1260724.
    1. Lau E, Papaioannou A, Dolovich L, Adachi J, Sawka AM, Burns S, et al. Patients’ adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Physician. 2008;54:394.
    1. Dolovich L, Nair K, Sellors C, Lohfeld L, Lee A, Levine M. Do patients’ expectations influence their use of medication? Can Fam Physician. 2008;54(3):384.
    1. Ministry of Health: Drugs and Devices Division . Ontario drug programs reference manual (edition 2, 45-48). Queen’s printer for Ontario. 2021. Section 5: standard online claims.
    1. Schwalm JD, Ivers NM, Natarajan MK, Taljaard M, Rao-Melocini P, Witteman HO, et al. Cluster randomized controlled trial of delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI) Am Heart J. 2015;170:903. doi: 10.1016/j.ahj.2015.08.014.
    1. Schwalm JD, Ivers NM, Bouck Z, Taljaard M, Natarajan MK, Dolovich L, et al. Length of initial prescription at hospital discharge and long-term medication adherence for elderly, post-myocardial infarction patients: protocol for an interrupted time series study. JMIR Res Protoc. 2020;9(11):e18981. doi: 10.2196/18981.
    1. Ramsay C, Matowe L, Grilli R, Grimshaw JM, Thomas RE. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behaviour change strategies. Int J Technol Assess Health Care. 2003;19(4):613–623. doi: 10.1017/S0266462303000576.
    1. Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, et al. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: a review. J Clin Epidemiol. 2020;122:1–11. doi: 10.1016/j.jclinepi.2020.02.006.
    1. Kozma CM, Dickson M, Phillips AL, Meletiche DM. Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis. Patient Prefer Adherence. 2013;12(7):509–516. doi: 10.2147/PPA.S40736.
    1. Turner SL, Forbes AB, Karahalios A, Taljaard M, McKenzie JE. Evaluation of statistical methods used in the analysis of interrupted time series studies: a simulation study. BMJ Open. 2019;9:e024096. doi: 10.1136/bmjopen-2018-024096.
    1. Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension. 2021;79(1):e1–e14.
    1. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011. doi: 10.1002/14651858.CD000011.pub4.
    1. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
    1. United Kingdom National Health Service. (2019). Being discharged from hospital..
    1. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309. doi: 10.1046/j.1365-2710.2002.00430.x.
    1. Lane D, Lawson A, Burns A, Azizi M, Burnier M, Jones DJL, et al. Nonadherence in hypertension: how to develop and implement chemical adherence testing. Hypertension. 2022;79(1). 10.1161/HYPERTENSIONAHA.121.17596 Epub 2021 Nov 5.

Source: PubMed

3
구독하다